Search - tctmd.com

Displaying 141 - 160 of 296

Sort: Relevancy | Date

News Daily News

Apixaban May Be Best DOAC for Frail, Older Patients With AF

Todd Neale

July 19, 2021

News Daily News

Making the Case for Sex-Specific CVD Guidelines

L.A. McKeown

July 08, 2021

News Daily News

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Michael O'Riordan

June 18, 2021

News Daily News

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

L.A. McKeown

June 16, 2021

News Daily News

CVST Risk Far Lower With Viral-Vector Vaccines Than With COVID-19 Itself

Todd Neale

June 10, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Conference News ACC 2021

Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics

L.A. McKeown

May 24, 2021

News Conference News ACC 2021

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

L.A. McKeown

May 16, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Conference News SCAI 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Michael O'Riordan

May 06, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear

Shelley Wood

March 17, 2021

News Daily News

Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD

Michael O'Riordan

February 19, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Michael O'Riordan

January 05, 2021

News Daily News

Review Spotlights SCAD Diagnosis and Treatment

L.A. McKeown

December 15, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Conference News AHA 2020

Rilonacept Prevents Recurrent Pericarditis: RHAPSODY

Shelley Wood

November 17, 2020

Advertisement

Apixaban May Be Best DOAC for Frail, Older Patients With AF

Making the Case for Sex-Specific CVD Guidelines

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

CVST Risk Far Lower With Viral-Vector Vaccines Than With COVID-19 Itself

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear

Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD

February 2021 News Roundup

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Review Spotlights SCAD Diagnosis and Treatment

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Rilonacept Prevents Recurrent Pericarditis: RHAPSODY

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content